Hana Pharm Co., Ltd. (293480.KS)
KSE · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩8,170 (-0.49%) as of
Key statistics
- Market cap
- 144.80B
- Dividend yield
- 3.17%
- 52-week range
- 8,050.00 – 11,990.00
- Beta
- 0.36
- Revenue (TTM)
- 139.33B
- Profit margin
- 17.44%
- Volume
- 15.91k
About Hana Pharm Co., Ltd.
Hana Pharm Co., Ltd. develops and provides various pharmaceutical products in South Korea and internationally. It offers anesthetics, narcotic analgesics, antiemetics, muscle relaxants, cardiovascular and endocrine system, gastrointestinal system, respiratory system, antibiotics, dermatology, urinology, osteoporosis, and central nervous system products, as well as analgesics, antipyretics, and anti-inflammatory drugs. The company was founded in 1996 and is headquartered in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Seoul, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.